Austria: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Austria

The Austrian prophylactic medicaments containing insulin market reached $X in 2022, picking up by 2% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption, however, saw a modest expansion. Over the period under review, the market reached the maximum level at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Austria

In 2022, shipments abroad of medicaments containing insulin but not antibiotics in measured doses increased by 14% to X tons, rising for the second consecutive year after four years of decline. Over the period under review, exports saw resilient growth. The growth pace was the most rapid in 2015 with an increase of 353% against the previous year. The exports peaked at X tons in 2016; however, from 2017 to 2022, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports contracted to $X in 2022. In general, exports saw a remarkable increase. The pace of growth was the most pronounced in 2021 with an increase of 244%. As a result, the exports attained the peak of $X, and then shrank in the following year.

Exports by Country

The UK (X tons), Germany (X tons) and the Czech Republic (X kg) were the main destinations of prophylactic medicaments containing insulin exports from Austria, together comprising 98% of total exports.

From 2012 to 2022, the biggest increases were recorded for the UK (with a CAGR of +86.2%), while shipments for the other leaders experienced mixed trend patterns.

In value terms, the UK ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Austria, comprising 63% of total exports. The second position in the ranking was taken by Germany ($X), with a 29% share of total exports. It was followed by Slovenia, with a 6% share.

From 2012 to 2022, the average annual growth rate of value to the UK stood at +119.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: Germany (-0.9% per year) and Slovenia (+11.7% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, reducing by -22.9% against the previous year. Over the period under review, the export price recorded a pronounced setback. The most prominent rate of growth was recorded in 2017 when the average export price increased by 60% against the previous year. Over the period under review, the average export prices hit record highs at $X per ton in 2013; however, from 2014 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Slovenia ($X per ton), while the average price for exports to Germany ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the United Arab Emirates (+958.3%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Austria

For the third consecutive year, Austria recorded decline in purchases abroad of medicaments containing insulin but not antibiotics in measured doses, which decreased by -1.9% to X tons in 2022. Overall, imports, however, recorded a relatively flat trend pattern. The growth pace was the most rapid in 2015 when imports increased by 24%. Over the period under review, imports attained the peak figure at X tons in 2017; however, from 2018 to 2022, imports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports amounted to $X in 2022. The total import value increased at an average annual rate of +1.7% from 2012 to 2022; however, the trend pattern remained consistent, with only minor fluctuations being observed in certain years. The growth pace was the most rapid in 2013 with an increase of 23% against the previous year. Imports peaked at $X in 2020; however, from 2021 to 2022, imports stood at a somewhat lower figure.

Imports by Country

Denmark (X tons), Germany (X tons) and France (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Austria, together comprising 96% of total imports. Ireland and Italy lagged somewhat behind, together accounting for a further 2.3%.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Ireland (with a CAGR of +163.5%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Denmark ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to Austria, comprising 55% of total imports. The second position in the ranking was held by Germany ($X), with a 25% share of total imports. It was followed by France, with a 14% share.

From 2012 to 2022, the average annual growth rate of value from Denmark amounted to +5.8%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (+10.4% per year) and France (-8.9% per year).

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, rising by 6% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of +1.5%. The growth pace was the most rapid in 2018 when the average import price increased by 31% against the previous year. The import price peaked in 2022 and is expected to retain growth in the near future.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for Ireland ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (+3.9%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :